Over the past year, activist investors have increased their influence in the healthcare sector, targeting companies like Medtronic, Pfizer, and CVS Health to advocate for enhanced performance and ...

Medtronic posted better-than-expected earnings, lifted its sales forecast, and faces analyst debate on growth prospects and ...

Jellison currently serves as a Senior Advisor for Astor Place Holdings, the Private Equity arm of Select Equities, and ...

Medtronic said on Tuesday it would add two new directors to its board and set up committees to help boost its lagging shares ...

UBS raised the firm’s price target on Medtronic (MDT) to $95 from $94 and keeps a Neutral rating on the shares. Medtronic now has the pieces in ...